Cline Christopher R.
Insider CIK 1943192 · TVTX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 20,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 1,900 | $63.69 | $121.0K | 87,908 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 20,735 | $62.61 | $1.30M | 89,808 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 400 | $65.31 | $26.1K | 87,508 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 20,000 | $17.44 | $348.8K | 138,016 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 27,473 | $62.00 | $1.70M | 110,543 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 20,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 400 | $65.31 | $26.1K | 87,508 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 1,900 | $63.69 | $121.0K | 87,908 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 20,735 | $62.61 | $1.30M | 89,808 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 27,473 | $62.00 | $1.70M | 110,543 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 20,000 | $17.44 | $348.8K | 138,016 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-03 | 642 | $66.37 | $42.6K | 118,016 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-03 | 642 | $66.37 | $42.6K | 118,016 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-06 | 310 | $43.95 | $13.6K | 118,658 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-05-05 | 2026-05-06 | 2,181 | $46.65 | $101.7K | 118,968 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-05-04 | 2026-05-06 | 4,250 | — | $0 | 4,250 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-05-04 | 2026-05-06 | 8,500 | — | $0 | 8,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-05-04 | 2026-05-06 | 4,250 | — | $0 | 121,149 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-15 | 1,014 | $42.61 | $43.2K | 116,899 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-15 | 9 | $41.07 | $370 | 125,152 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-14 | 2026-04-15 | 7,239 | $41.93 | $303.5K | 117,913 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-13 | 2026-04-15 | 65 | $28.85 | $1.9K | 125,161 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-04-13 | 2026-04-15 | 14,000 | — | $0 | 125,226 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-04 | 2026-02-05 | 1,635 | $32.14 | $52.5K | 111,336 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-04 | 2026-02-05 | 110 | $32.90 | $3.6K | 111,226 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-03 | 2026-02-03 | 7,242 | $32.12 | $232.6K | 112,971 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-01-31 | 2026-02-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-01-31 | 2026-02-03 | 28,130 | — | $0 | 120,213 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-12-01 | 2025-12-03 | 20,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-12-01 | 2025-12-03 | 20,000 | $16.23 | $324.6K | 112,083 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-12-01 | 2025-12-03 | 20,000 | $35.01 | $700.2K | 92,083 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-09-04 | 2025-09-05 | 119 | $19.71 | $2.3K | 92,083 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-09-03 | 2025-09-05 | 454 | $18.20 | $8.3K | 92,202 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-08-27 | 2025-08-28 | 470 | $17.31 | $8.1K | 92,656 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-05-05 | 2025-05-05 | 1,784 | $21.05 | $37.6K | 93,126 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-05-02 | 2025-05-05 | 4,920 | — | $0 | 4,920 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-05-02 | 2025-05-05 | 4,920 | — | $0 | 94,910 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-04-11 | 2025-04-14 | 48 | $13.14 | $631 | 89,990 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 5,192 | $20.12 | $104.5K | 90,038 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 58,000 | — | $0 | 58,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-01-31 | 2025-02-04 | 21,500 | — | $0 | 95,230 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-01-22 | 2025-01-23 | 865 | $18.94 | $16.4K | 73,730 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-09-09 | 2024-09-09 | 2,490 | $11.52 | $28.7K | 74,595 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-09-05 | 2024-09-09 | 6,750 | — | $0 | 77,085 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-09-04 | 2024-09-05 | 514 | $9.51 | $4.9K | 70,335 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-04-11 | 2024-04-12 | 54 | $6.74 | $364 | 70,849 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 3,818 | $8.53 | $32.6K | 70,903 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 25,000 | — | $0 | 74,721 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 853 | $9.07 | $7.7K | 49,721 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-09-05 | 2023-09-05 | 457 | $14.71 | $6.7K | 50,574 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-05-10 | 2023-05-12 | 455 | $16.59 | $7.5K | 51,031 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-04-11 | 2023-04-13 | 47 | $21.49 | $1.0K | 51,486 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-02 | 1,588 | $21.75 | $34.5K | 51,533 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 6,750 | — | $0 | 6,750 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 54,500 | — | $0 | 54,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-01-31 | 2023-02-02 | 20,250 | — | $0 | 53,121 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-01-24 | 2023-01-26 | 852 | $21.90 | $18.7K | 32,871 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-09-01 | 2022-09-01 | 48,000 | — | $0 | 48,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-09-01 | 2022-09-01 | 9,840 | — | $0 | 9,840 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-09-01 | 2022-09-01 | 5,000 | — | $0 | 33,723 | SEC↗ |